Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
Welcome to
our Blog
Here you can learn about the latest biometric developments for your sector
GMP compliance in drug manufacturing
The pharmaceutical industry must ensure compliance with GMP regulations, which include a number of issues, including data integrity. The adoption of biometric technologies, such as iris or fingerprint recognition, emerges as the solution to ensure compliance.
GxP environments and their relevance to the pharmaceutical industry
Within GxP regulated environments, it is essential to ensure data integrity and traceability of actions throughout the supply chain. The adoption of biometric technologies, such as iris or fingerprint recognition, emerges as the solution to ensure compliance.
Consequences of non-compliance with data integrity in the pharmaceutical industry
Non-compliance with GMP regulations, particularly in critical factors such as data integrity and employee identification in manufacturing tasks, can lead to regulatory agencies issuing warning letters and even suspending manufacturing operations. How do you effectively address and prevent these consequences to ensure compliance?
FDA inspections in the pharmaceutical industry
The FDA and EMA share the goal of ensuring compliance with GMP and other applicable regulations in pharmaceutical manufacturing. These entities carry out exhaustive inspections of companies to verify their compliance with established standards. Is your company ready to face the rigorous inspection processes?
Challenges of using RFID cards in the pharmaceutical industry
RFID cards provide some advantages when used for access control and as an electronic signature for employees in pharmaceutical production processes. However, they present a series of inconveniences that make the regulations themselves not accept them as the exclusive method of identification.
What are the disadvantages of using handwritten signatures in pharmaceutical process control?
In many pharmaceutical companies, employees record their manufacturing actions on paper with handwritten signatures, which creates risks and inefficiencies. It is possible to digitize these processes in a simple way and add the security of the biometric electronic signature.
Challenges in the control of pharmaceutical manufacturing processes on paper
In many pharmaceutical companies, employees still record manufacturing control data on paper and authenticate it with their handwritten signature. This can lead to inefficiencies and errors that jeopardize data integrity.
Biometric electronic signature in pharmaceutical manufacturing processes
The use of biometrics in electronic signatures solves all the current problems with passwords in GMP regulated pharmaceutical manufacturing environments. But what technologies should we use? How should they be applied?
Introduction to applied biometrics
Biometrics allow people to be identified safely, conveniently and quickly. We explain the fundamental aspects to know how to choose the most appropriate technologies and systems for each sector of activity.
Quality as a strategic focus in the pharmaceutical industry
Adopting a quality philosophy that goes beyond mere regulatory compliance is essential to standing out in the pharmaceutical industry. The integration of advanced technologies, such as biometrics, represents an effective solution to ensure regulatory compliance and achieve superior quality standards.
Fingerprint biometrics: The oldest form of biometric identification.
Fingerprint biometrics is recognized as a highly secure identification method. Today, its use has expanded beyond the realm of security, and it is widely used to manage identities and control access in a variety of industries.
Fingerprints, faces or irises? We explore the features of the main biometric technologies
Biometrics offers a secure, convenient and fast way to identify people. We analyze the characteristics of the main biometric technologies, such as iris, facial and fingerprint recognition, considering the advantages and disadvantages they provide.
Ensuring the integrity of data collected in clinical trial EDCs with biometric technology
Ensuring the integrity of data collected in clinical trials is essential and represents a critical step in the introduction of new drugs to the market. The implementation of biometric electronic signatures in Electronic Data Capture (EDCs) ensures their accuracy and reliability.
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
Subscribe to our newsletter
Receive information of interest about biometrics for your sector
